Ali Syed Arbab
Elsevier Science
e druk, 2021
9780128225271
New Targeting in The Reversal of Resistant Glioblastomas
Specificaties
Gebonden, blz.
|
Engels
Elsevier Science |
e druk, 2021
ISBN13: 9780128225271
Rubricering
Onderdeel van serie
Cancer Sensitizing Agents for Chemotherapy
Levertijd ongeveer 8 werkdagen
Samenvatting
New Targeting in The Reversal of Resistant Glioblastomas discusses alternative treatment strategies that not only target tumor cells but also target the tumor microenvironment, metabolic pathways and interaction of cytokines in tumor cells. The current treatment for primary and recurrent glioblastomas is failing because clinicians are not considering the effect of bone marrow derived cells to the development of resistance to clinically practiced therapies. This book helps readers rethink treatment strategies to successfully fight glioblastomas. It is a valuable resource for cancer researchers, clinicians, graduate students and other members of the biomedical field.
Specificaties
Inhoudsopgave
<p>1. Current status of recurrent glioblastoma therapies</p> <p>2. Imaging of glioblastoma recurrence</p> <p>3. Overarching therapeutic challenges and arachidonic acid metabolism as a novel target in glioblastoma</p> <p>4. The intervention of IL-8-CXCR2 axis to reverse the resistance to GBM therapies</p> <p>5. Targeting Glioma Stem Cell Metabolism to Enhance Therapy Responses and Minimize Resistance</p> <p>6. Targeting Tumor Microenvironment Associated Cells to Reverse Therapy Resistance</p> <p>7. Recent Progress in Immunotherapy for Glioblastoma</p> <p>8. The Role of Convection Enhanced Deliver in the Treatment of GBM</p> <p>9. TBA Sensitization of Resistant GBM to Radiation</p>